Hydroxyapatite Market Size 2022, Demand, Price Trends and Report by 2027
According to IMARC Group’s new report “Hydroxyapatite Market: Worldwide Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global hydroxyapatite market size was $2.27 billion in 2021. By 2027, the IMARC Group forecasts the market will be worth $3.19 billion at a compound annual growth rate (CAGR) of 5.70 percent from 2022 to 2027.
Bone, fish scales, eggshells, and other biological materials can all be converted into hydroxyapatite (Ca10(PO4)6(OH)2), an inorganic calcium phosphate mineral. The serum calcium to phosphorous (Ca/P) ratio and the hexagonal structure of this compound are both identical to that of bone apatite, another type of hard tissue. Hydroxyapatite is thermodynamically stable at a wider range of temperatures and pH values than calcium phosphates. Superior remineralization of enamel compared to saliva, enhanced bone healing at the bone-implant interface, compositional similarity to bone minerals, etc. are just some of the benefits of hydroxyapatite. That’s why you’ll find it in a wide variety of bone grafts or fillers, orthopaedic and dental care devices, and coatings meant to roughen the surface of metal implants. These days, hydroxyapatite is typically separated into nano and micro varieties.
We are keeping close tabs on how COVID-19 is affecting the market both directly and through reverberating effects in related fields. The report will be updated to include your comments.
Request a free sample brochure: https://www.imarcgroup.com/hydroxyapatite-market/requestsample
Hydroxyapatite Market Trends and Drivers:
The hydroxyapatite market is being driven by a number of reasons, including the rising incidence of cardiovascular diseases (CVDs) and the rising need for bone grafts, transplants, bioactive ceramics, etc. In addition, increased instances of dermatological problems, particularly among the elderly population, and a more self-aware customer base are driving the market forward. Nano-increasing hydroxyapatite’s use as a desensitising agent to lessen tooth sensitivity and cut down on plaque levels prior to teeth whitening, as well as in the delivery of drugs and genes, in bone tissue engineering and fillers, and in other applications, is positively impacting the global market. Hydroxyapatite’s many advantages, including as its bioactivity, osteoconductive, non-toxic, and non-inflammatory qualities, are also contributing to the industry’s expansion. Market growth for hydroxyapatite is anticipated to be driven by the substance’s increasing acceptance as a fluoride replacement.
Hydroxyapatite Market Report Segmentation:
The research analyses the market’s competitive landscape by providing in-depth profiles of the industry’s leading companies.
Bio-Rad Laboratories, Inc., APS Materials, Inc., Berkeley Advanced Biomaterials, CAM Bioceramics B.V., Cgbio, Fluidinova S.A., HOYA Technosurgical Corporation (Hoya Corporation), Medtronic, Plc., Merz Pharma GmbH & Co. KGaA, SigmaGraft Biomaterials, SofSera Corporation, Taihei Chemical Industrial Co., Ltd., and Zimmer Biomet.
The market is broken down in this research into the following sections:
Breakup by Type:
- Greater than Micrometer
Breakup by Application:
- Dental Care
- Plastic Surgery
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
When it comes to management strategy and market research, IMARC Group is the gold standard. We work with companies from various industries and all over the world to help them find the most lucrative possibilities, conquer their biggest obstacles, and ultimately revolutionise their industries.
Key market, scientific, economic, and technical advances are only some of the topics covered by IMARC’s offerings, which are aimed at the C-suites of pharmaceutical, industrial, and high-tech corporations. The organisation is a leader in market research and analysis for such diverse fields as nanotechnology, new processing techniques, nanomaterials, biotechnology, pharmaceuticals, food and beverage, travel and tourism, and more.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800